Addition of adenoviral vector targeting of chemotherapy to the MUC-1/ecdCD40L VPPP vector prime protein boost vaccine prolongs survival of mice carrying growing subcutaneous deposits of Lewis lung cancer cells-Reference-Cited by-同舟云学术

Addition of adenoviral vector targeting of chemotherapy to the MUC-1/ecdCD40L VPPP vector prime protein boost vaccine prolongs survival of mice carrying growing subcutaneous deposits of Lewis lung cancer cells

Published:2010-07-01 Issue:11 Volume:17 Page:1333-1340
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Akbulut H,Tang Y,Akbulut K G,Maynard J,Deisseroth A

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt201093.pdf

Reference33 articles.

1. Deng Y, Jing Y, Campbell AE, Gravenstein S . Age-related impaired type 1T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004; 172: 3437–3446.

2. Weinberg AD, Thalhofer C, Morris N, Walker JM, Seiss D, Wong S et al. Anti-OX40 (CD134) administration to nonhuman primates: immunostimulatory effects and toxicokinetic study. J Immunother 2006; 29: 575–585.

3. Eaton SM, Burns EM, Kusser K, Randall TK, Haynes L . Age-related defects in CD4T cells cognate helper function lead to reductions in humoral responses. J Exp Med 2004; 200: 1613–1622.

4. Dong L, Mori I, Hossain J, Liu B, Kimura Y . An immunostimulatory oligodeoxynucleotide containing a cytidine-guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 response. J Gen Virol 2003; 84: 1623–1628.

5. Zhang L, Tang YC, Akbulut H, Zelterman D, Linton P-J, Deisseroth A . An adenoviral vector cancer vaccine. Proc Natl Acad Sci USA 2003; 100: 15202–15206.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the tumor microenvironment: mesenchymal stem cell-mediated delivery of anticancer agents;Journal of Drug Targeting;2024-05-06

2. Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies;Cancers;2022-12-26

3. Immune gene therapy of cancer;TURKISH JOURNAL OF MEDICAL SCIENCES;2020-11-03

4. A Bicistronic Adenoviral Vector Carrying Cytosine Deaminase and Granulocyte-Macrophage Colony-Stimulating Factor Increases the Therapeutic Efficacy of Cancer Gene Therapy;Human Gene Therapy;2019-08

5. The Current Status of Immunotherapy in Thoracic Malignancies;Immune Checkpoint Inhibitors in Cancer;2019